Clinical trials
Recruiting Phase 2 trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 11 |
| 2025 | 12 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tata Memorial Centre | 10 |
| Eli Lilly and Company | 6 |
| Novo Nordisk A/S | 3 |
| Pfizer | 3 |
| AstraZeneca | 2 |
| Boehringer Ingelheim | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Novartis Pharmaceuticals | 2 |
| Pharmazz, Inc. | 2 |
| Tata Memorial Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 4 |
| Hematologic Neoplasms | 4 |
| Asthma | 2 |
| Glioblastoma | 2 |
| Gram-Negative Bacterial Infections | 2 |
| Heart Failure | 2 |
| Inflammatory Bowel Diseases | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Anemia, Sickle Cell | 1 |
| Asphyxia Neonatorum | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.